blackolive brokers around 770 sqm of office space to Chugai Pharma Germany GmbH
Frankfurt / 12.07.2022
Chugai Pharma Germany GmbH, part of an internationally active, research-oriented Japanese pharmaceutical company, is signing a new, long-term lease for around 770 sqm at FLOW, Amelia-Mary-Earhart-Strasse 11-13 in Frankfurt. blackolive, a member of German Property Partners (GPP), acted as advisor to the company.
"In the course of blackolive's expert and goal-oriented advice, we were able to find the ideal rental space for our office. The move from Niederrad to the FLOW is the next step in driving our new, modern working concept. Our vision 'The Power of together' is also reflected in our strategically developed concept. The focus is on the employees: all working needs are catered for in the best possible way and spatial hierarchies are abolished at the same time. Be it open work areas, creative spaces, sound-absorbing think tanks or creative meeting areas. The appropriate modern IT forms the framework not only to map all security measures in the best possible way, but also enables our high standard for hybrid working," says Oliver Pfeiffer, Director Corporate Services and Finance and authorised signatory at Chugai Pharma Germany GmbH.
Located in the centre of the new "Gateway Gardens" district, FLOW offers approx. 31,500 sqm of modern office rental space with high-quality fittings. The property, with its elegantly curved, gleaming white façade, has flexible floor plans and a comprehensive range of services. The green inner courtyard of the DGNB Gold pre-certified building invites you to linger. In addition, the property, which is located directly at the airport, is characterised by excellent transport connections.
Chugai has been intensively involved in the German healthcare market since 1998. The company has become a reliable partner for doctors, pharmacists, medical assistants and patients in Germany in the fields of oncology, rheumatology and haemophilia. Chugai Pharma Germany GmbH, based in Frankfurt am Main, is a wholly owned subsidiary of Chugai Pharma Europe Ltd (London/ United Kingdom), which markets and distributes preparations for the treatment of diseases in the fields of oncology, haemophilia and rheumatology with approximately 60 employees.